share_log

BRIEF-Synthetic Biologics Provides Update On Syn-020 Intestinal Alkaline Phosphatase Phase 1 Single-Ascending Dose Clinical Trial

路透社 ·  Jun 29, 2021 07:19
June 29 (Reuters) - Synthetic Biologics Inc :
   * SYNTHETIC BIOLOGICS PROVIDES UPDATE ON SYN-020 INTESTINAL ALKALINE PHOSPHATASE PHASE 1 SINGLE-ASCENDING DOSE CLINICAL TRIAL
   * SYNTHETIC BIOLOGICS INC - ANALYSES OF PRELIMINARY DATA DEMONSTRATED THAT SYN-020 MAINTAINED A FAVORABLE SAFETY PROFILE, WAS WELL TOLERATED

Source text for Eikon:  Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment